GENinCode (LON:GENI) Shares Up 110.2% – Still a Buy?

GENinCode Plc (LON:GENIGet Free Report) shot up 110.2% during mid-day trading on Thursday . The company traded as high as GBX 6.95 ($0.09) and last traded at GBX 6.73 ($0.08). 7,091,908 shares traded hands during mid-day trading, an increase of 1,322% from the average session volume of 498,732 shares. The stock had previously closed at GBX 3.20 ($0.04).

GENinCode Stock Performance

The stock’s 50 day moving average price is GBX 3.80 and its 200 day moving average price is GBX 5.16. The company has a market capitalization of £11.97 million, a P/E ratio of -135.32 and a beta of 0.66. The company has a debt-to-equity ratio of 9.27, a quick ratio of 15.89 and a current ratio of 2.60.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Featured Articles

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.